ALIM logo

Alimera Sciences Inc.

ALIM

$3.75

- $0.08 (-2.11%) This month

Closed: 1 Mar 2024 21:00 US/Eastern

Key details

CEO

Richard Eiswirth

Employees

487

Headquarters

Alpharetta, US

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

About Alimera Sciences Inc.

alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG